Prahlad Singh (MBA '00) is President and Chief Executive Officer at Revvity (formerly known as PerkinElmer), as well as a member of the Board of Directors. Previously, Prahlad was the President and Chief Operating Officer of the Company since January 2019. Prahlad joined the company in May 2014 as President of the Diagnostics business. Prior to that, he was General Manager of GE's Women's health business. Before that, he held senior executive-level roles in Strategy, Business Development, and M&A at both GE and Philips Healthcare. From 1995 to 2007, he held leadership roles of increasing responsibility at DuPont Pharmaceuticals and subsequently Bristol Myers Squibb Medical Imaging, which included managing the Asia Pacific and Middle East regions.
Prahlad holds a Ph.D. in Chemistry from the University of Missouri-Columbia and an MBA from Northeastern University. His technical work resulted in several peer-reviewed publications and global patents. Prahlad joined CEM's board in 2018.